Genomic Health, Inc. (NASDAQ:GHDX)

CAPS Rating: 5 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Recs

2
Player Avatar nilamr (68.34) Submitted: 8/1/2010 2:33:15 PM : Outperform Start Price: $13.00 GHDX Score: +90.31

Good mgmt, mgmt have skin in the game, growing field, great execution in building payment from insurance companies.

Featured Broker Partners


Advertisement